Penmenvy, meningococcal vaccine, approved by FDA to help protect against MenABCWY – GSK
GSK plc announced that the FDA has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25 years. The… read more.